WisdomTree Insights

We recently rebalanced our ex-State-Owned Enterprises China Index (CHXSOE). Liqian Ren highlights three major changes.
Read the article
Emerging markets are entering 2022 from a low base after their economic recovery was hindered by the resurgence of COVID-19 variants, China’s regulatory crackdown and concerns of a more hawkish Federal Reserve. Against this backdrop, Aneeka Gupta explains why investors should not ignore emerging markets this year.
Read the article

After an eventful year, many investors are asking: is investing in ex-state-owned companies in emerging markets still better than investing in the full market? Alejandro Saltiel explains why our answer is, yes.

Read the article

For many emerging markets (EM) investors, navigating 2021 has felt like walking through a minefield. Joe Tenaglia explains how small caps have served as a quiet bright spot for EM investors.

Read the article

The financial world seems fixated on Evergrande, the Chinese real estate company with a larger-than-life CEO and larger-than-average debt burden. Liqian Ren analyzes this latest event’s potential impact on the Chinese equity market.

Read the article

VIE (variable interest entity) default risk is almost unavoidable when it comes to investing in China. Liqian Ren discusses how investors can assess and limit their exposure to VIE in their emerging markets portfolio. 

Read the article